Qingdao NovelBeam Technology Co. Ltd. A - Asset Resilience Ratio
Qingdao NovelBeam Technology Co. Ltd. A (688677) has an Asset Resilience Ratio of 2.66% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688677 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how Qingdao NovelBeam Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 688677 current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Qingdao NovelBeam Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Qingdao NovelBeam Technology Co. Ltd. A total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥43.22 Million | 2.66% |
| Total Liquid Assets | CN¥43.22 Million | 2.66% |
Asset Resilience Insights
- Limited Liquidity: Qingdao NovelBeam Technology Co. Ltd. A maintains only 2.66% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Qingdao NovelBeam Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Qingdao NovelBeam Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for Qingdao NovelBeam Technology Co. Ltd. A (2023–2025)
The table below shows the annual Asset Resilience Ratio data for Qingdao NovelBeam Technology Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.67% | CN¥43.57 Million ≈ $6.38 Million |
CN¥1.63 Billion ≈ $239.21 Million |
-0.09pp |
| 2023-12-31 | 2.76% | CN¥38.45 Million ≈ $5.63 Million |
CN¥1.39 Billion ≈ $204.11 Million |
-- |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more